Clinical trial
Toripalimab Combined With Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multi-center, Randomized Controlled Trial
NCT04907370 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Toripalimab Combined With Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multi-center, Randomized Controlled Trial
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- August 1, 2021
- Completion date
- March 1, 2027
- Enrollment
- 532 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.